In reply to @fourdollars
Saul Priceman moved on from City of Hope Hospital for a career progression opportunity; he hasn’t left the IMU scientific board. I don’t understand why people are obsessed by this because his role in developing onCARlytics is now complete and like the rest of us, he’s waiting to see how it goes in clinical trials.
Yuman Fong isn’t involved in running the CF33 based drug clinical trials. His role in developing the drugs is complete and like the rest of us, he’s waiting to see how it goes in the clinical trials. When he has made comments about CF33 based drugs, it has been during presentations he was invited to by IMU. I don’t understand why anyone would expect commentary from him at this stage of the trials.
I would love it if someone could explain why Yuman or Saul should be making further comments while we’re part way through the Ph1? And what it is that they should be saying that they haven’t already said?
Media Thread, page-13692
-
- There are more pages in this discussion • 694 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
0.003(5.56%) |
Mkt cap ! $417.2M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.8¢ | 5.2¢ | $2.499M | 45.00M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1921794 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 1368288 | 7 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |